香港股市 已收市

Alcon Inc. (ALC.SW)

Swiss - Swiss 延遲價格。貨幣為 CHF。
加入追蹤清單
80.22-0.10 (-0.12%)
收市:05:30PM CEST

Alcon Inc.

Chemin de Blandonnet 8
Vernier
Geneva 1214
Switzerland
41 589 112 110
https://www.alcon.com

版塊Healthcare
行業Medical Instruments & Supplies
全職員工25,000

高階主管

名稱頭銜支付行使價出生年份
Mr. F. Michael BallExecutive Chairman1.05M1955
Mr. David J. EndicottCEO & Director4.46M1965
Mr. Arthur B. Cummings M.D.Executive Director255.91k1962
Mr. Timothy C. StonesiferChief Financial Officer1967
Margaret BuckleyChief Accounting Officer
Dr. Franck LeveillerSenior VP, Head of Global R&D and Chief Scientific Officer
Ms. Sue-Jean LinSenior VP and Chief Information & Transformation Officer1959
Mr. Royce R. BedwardSenior VP, General Counsel & Corporate Secretary1966
Ms. Kimberly MartinSenior VP, Chief HR Officer & Corporate Communications1975
Mr. Laurent AttiasHead of Corporate Development, Strategy, BD&L and M&A1968
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CHF。

描述

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

公司管治

截至 2024年6月29日 止,Alcon Inc. 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中:5;董事會:3;股東權利:1;現金賠償:1。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。